What were some of your most satisfying successes of the past year, and why? It's always exciting when a deal is identified as the first-of-its-kind, as in the GW Pharmaceuticals acquisition by Jazz Pharmaceuticals, which was the largest cannabis industry deal to date. Similarly, the Johnson & Johnson separation is definitely a highlight of the past year. Being able to guide them through this transformative time is a huge tribute to the Firm's lasting relationship and our ability to give commercial advice.